Results from the ReOpen1 and ReOpen2 trials, both spanning 24 weeks, revealed that XHANCE significantly improved symptoms, sinus opacification, and quality of life for CRS patients, regardless of ...

Among patients reporting any perceived degree of disease improvement despite treatment, mean changes in in CT scans of sinuses as scored by sinus opacification were at least –2.86, or at least ...

The EDS-FLU improved symptoms and sinus opacification in patients with chronic rhinosinusitis without nasal polyps.

The drug showed a 42% and 27% improvement in sinus opacification versus 4% and 0% with placebo in SINUS-24 and SINUS-52 respectively – and at 52 weeks in SINUS-52, a 37% improvement in sinus ...

A 10-year-old boy presents with sudden pain and swelling over his forehead with severe headache over the last 24 hours. His history was positive for sustaining a head injury while skateboarding ...

For an adult with chronic rhinosinusitis, the surgeon should not endorse or require a predefined regimen or duration of medical therapy as a prerequisite to sinus surgery. HealthDay News — In a ...

At 24 weeks, patients on the biologic experienced a 42% and 27% improvement in sinus opacification compared with 4% and 0% with placebo in SINUS-24 and SINUS-52, respectively.